Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy [NA]
This clinical trial update outlines a study to define the role of palliative care for patients with hematologic malignancies undergoing adop…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of Thiotepa Combination With Melphalan (TM Protocol) Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma：A Prospective Randomized Controlled Clinical Trial [NA]
A prospective randomized trial evaluating thiotepa in combination with melphalan as conditioning therapy for autologous stem cell transplant…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: REal World MAIA UK OutcomEs
Update on a real-world UK outcomes study related to multiple myeloma is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma [Phase 2]
Phase 2 study evaluating iberdomide versus observation off therapy after idecabtagene vicleucel CAR-T therapy in adults with multiple myelom…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma. [EARLY_Phase 1]
A Phase 1 clinical study to evaluate the safety and preliminary efficacy of QI-019B in patients with relapsed or refractory multiple myeloma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: CAR T-cell Therapy in Patients With Renal Dysfunction [Phase 2]
A Phase 2 clinical trial evaluating CAR T-cell therapy in patients with renal dysfunction is currently recruiting for indications including …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
The document reports specimen collection activities for the Agricultural Health Study pesticide exposure cohort, a National Cancer Institute…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma [NA]
This entry reports on a completed clinical trial called The Myeloma Pack, which evaluates a multi-modality educational intervention to engag…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Regeneron is conducting a Phase 1/2 clinical trial evaluating linvoseltamab in adults with relapsed or refractory multiple myeloma, and the …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy [NA]
A clinical trial update describes a University of Nebraska study evaluating prebiotics to improve gut microbiome diversity after autologous …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects [Phase 1]
This listing describes a Phase 1 clinical trial evaluating Cemsidomide in combination with Elranatamab for relapsed/refractory multiple myel…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel [Phase 2]
Phase 2 clinical trial update evaluating nivolumab in multiple myeloma patients who previously received idecabtagene vicleucel (ide-cel).
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma [Phase 1, Phase 2]
Update on a Phase 1/2 clinical trial evaluating a four-drug combination (carfilzomib, lenalidomide, dexamethasone, belantamab mafodotin) for…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) [Phase 2]
A Phase 2 study evaluating CyBorD (cyclophosphamide, bortezomib, dexamethasone) plus daratumumab in people with Monoclonal Gammopathy of Ren…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial comparing Etentamig plus daratumumab versus daratumumab, lenalidomide, and dexamethasone in adults with new…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) [Phase 4]
Pfizer's Phase 4 post-trial access study for Elranatamab in participants with multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Pre-malignant States to Hematologic Malignancies in Firefighters
A Wake Forest trial investigates progression from pre-malignant hematologic states to blood cancers in firefighters and is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: PET Imaging Study of 68Ga-NB381 in Multiple Myeloma [EARLY_Phase 1]
Clinical trial update describes a PET imaging study of 68Ga-NB381 for multiple myeloma in early Phase 1, currently recruiting. Sponsor: Peki…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma [Phase 1]
Phase 1 study evaluating CS1-CAR T cell therapy after chemotherapy in patients with relapsed or refractory CS1-positive multiple myeloma is …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide [Phase 1, Phase 2]
This registry entry describes a Phase 1/2 clinical trial at University of Alabama at Birmingham evaluating combination regimens that include…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy [NA]
This clinical trial update describes a study exploring voice as a way to monitor side effects in people receiving CAR T-cell therapy, includ…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab. [Phase 2]
Phase 2 study evaluating daratumumab in combination with teclistamab or talquetamab for frail patients with newly diagnosed multiple myeloma…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) [Phase 3]
Phase 3 clinical trial comparing BMS-986393 to standard regimens in adults with relapsed or refractory and lenalidomide-exposed multiple mye…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma [Phase 2]
Phase 2 trial evaluating the combination of cilta-cel (ciltacabtagene autoleucel) and talquetamab in high-risk multiple myeloma. The study s…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
This clinical trial update describes biospecimen procurement for the Center for Immuno-Oncology immunotherapy protocols. It covers recruitin…